Marketwatch.com recently published an article discussing “five value-stock picks that set up your portfolio for a pandemic recovery.”
The article discusses Raytheon Technologies (NYSE: RTX), which is down 30% this year as being one of them. Currently yielding 3.11%, compared to the 10-year note, you’ll be getting a healthy dividend while we wait for travel and defense to bounce back.
PPG Industries (NYSE: PPG) is another one that is down for the year, but only about 8%. The company makes paints and coatings to be used in various industries like auto and aircrafts. As these recover further, you’ll be getting paid almost 2% to park some money here.
Coca-Cola Co. (NYSE: KO) is stuck right in the middle of its march low’s and YTD highs. The company is knocking on strong resistance for the 4th time since April at $50.00 per share. Either way, here’s another strong dividend of almost 3.4%. Get paid to wait.
The article finishes with Abbott Laboratories (NYSE: ABT) and Home Depot (NYSE:HD), both of which are up dramatically and seem to be setting new high’s each day.
Hers’s one that did not make this list but has been showing an uptick in dollar volume as well as strong support at around $1.45 per share:
Now… More than 100 million U.S. adults are now living with diabetes or prediabetes, according to a new report released by the Centers for Disease Control and Prevention (CDC).
Take a look at Glucose Health, Inc. (OTC Pink: GLUC). Glucose Health manufacturers nutritional beverages for the diabetic-adult nutrition consumer retail category under the registered trademark GLUCODOWN®.
Glucose Health, Inc. is an under-the-radar company whose GLUCODOWN® products are found in major national pharmacy chains including Walmart (NYSE: WMT), CVS Health (NYSE: CVS) and even online at Amazon.com (NASDAQ: AMZN) yet is still trading below a $20 million valuation.
The company’s flagship product GLUCODOWN® is infused with a special form of diabetic fiber demonstrated in more than 20 clinical studies to help maintain glucose (blood sugar) levels in a normal healthy range.
Glucose Health, Inc. (OTC Pink: GLUC) just announced unprecedented consumer demand and 2nd quarter fiscal 2020 sales. 2nd quarter fiscal 2020 revenues increased 186% compared to the 2nd quarter of fiscal 2019 – Q2 2020 revenues were just $7,140 short of tripling 2nd quarter 2019 revenues.
What are the revenues of this company going to look like when the latest GLUCODOWN® numbers are reported for Q3 and Q4? Over the past 12 months, GLUC has seen a range of approximately $.20 – $1.90 per share and with only 12.5 million shares outstanding, GLUC could be the best value in the diabetic nutrition/medical foods space and should be on everybody’s watch list.
EmergingGrowth.com is a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies. Through its evolution, EmergingGrowth.com found a niche in identifying companies that can be overlooked by the markets due to, among other reasons, trading price or market capitalization. We look for strong management, innovation, strategy, execution, and the overall potential for long- term growth. Aside from being a trusted resource for the Emerging Growth info-seekers, we are well known for discovering undervalued companies and bringing them to the attention of the investment community. Through our parent Company, we also have the ability to facilitate road shows to present your products and services to the most influential investment banks in the space.